Less Chemo, Better Results for Kids With High-Risk Leukemia? What Families Should Know
A large new trial swapped two rounds of intense chemo for an immune drug called blinatumomab in 709 children with high-risk leukemia. Here are the results, the trade-offs, what it could mean, and three questions to bring to the care team.
The Galleri Cancer Blood Test: What the First Big Trial Found, and What It Means for You
One blood test that looks for many cancers at once just had its first large randomized trial. Here is what it found, the drawbacks that matter, what it could mean in the future, and three questions to bring to your next visit.
Hidden Artery Plaque Is More Common Than You Think. Here’s What to Ask For.
More than half of healthy adults in the REACT study already had plaque in their arteries, and risk calculators missed most of it. Here is what the study found, what it does not prove, and the three questions I would bring to your next visit.
Should You Get an Lp(a) Test? What a New Lancet Study Means for Your Care at ThriveMed
Most cholesterol panels skip lipoprotein(a), an inherited heart risk marker. Here is what a new Lancet study of Kylo-11 found, what it does not prove yet, and how to ask for the Lp(a) lab at ThriveMed.
DR. CHRIS BRAZZLE | WHAT DO YOU NEED TO BE A GREAT LEADER? | THRIVEMED TV
Check out this small clip from our interview with Dr. Chris Brazzle. His leadership principles help leaders inspire transformation in students and workers. Learn more about his principles at https://drchrisbrazzle.com/
DIANA SULLIVAN | THE INTENTION BEHIND COHOUSING | THRIVEMED TV
Diana Sullivan on cohousing
